A retrospective multicenter study from the pediatric IBD Porto group of ESPGHAN included 64 children with IBD (41 UC/IBD-U and 23 CD) refractory to TNF-α medications and reported a week 14 corticosteroid-free remission of 37% in UC and 14% in CD133. This evidence concerns the gene TNF and inflammatory bowel disease.